Capstone Investment Advisors, LLC Pfizer Inc Transaction History

Capstone Investment Advisors, LLC

$38 Billion
Q2 2025

A detailed history of Capstone Investment Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 271,283 shares of PFE stock, worth $6.74 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

271,283

Previous 145,977 85.84%

Holding current value

$6.74 Million

Previous $3.7 Million 77.75%

% of portfolio

0.02%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$21.59 - $24.84 $2.71 Million - $3.11 Million	125,306 Added 85.84%	271,283 $6.58 Million
Q1 2025 May 15, 2025	SELL	$25.01 - $27.13 $6.82 Million - $7.4 Million	-272,809 Reduced 65.14%	145,977 $3.7 Million
Q4 2024 Feb 14, 2025	BUY	$24.8 - $30.19 $2.83 Million - $3.44 Million	114,023 Added 37.41%	418,786 $11.1 Million
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $2.27 Million - $2.57 Million	-81,971 Reduced 21.2%	304,763 $8.82 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $305,646 - $358,160	12,100 Added 3.23%	386,734 $10.8 Million
Q1 2024 May 01, 2024	BUY	$25.89 - $29.73 $4.21 Million - $4.83 Million	162,511 Added 76.61%	374,634 $10.4 Million
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $6.86 Million - $8.92 Million	-262,690 Reduced 55.32%	212,123 $6.11 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $1.48 Million - $1.73 Million	46,150 Added 10.77%	474,813 $15.7 Million
Q2 2023 Aug 10, 2023	BUY	$36.12 - $41.79 $8.2 Million - $9.49 Million	227,067 Added 112.63%	428,663 $15.7 Million
Q1 2023 May 09, 2023	BUY	$39.39 - $51.28 $3.21 Million - $4.17 Million	81,415 Added 67.74%	201,596 $8.23 Million
Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $2.53 Million - $3.31 Million	-60,649 Reduced 33.54%	120,181 $6.16 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $5.54 Million - $6.77 Million	126,646 Added 233.73%	180,830 $7.91 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $20 Million - $23.7 Million	-429,168 Reduced 88.79%	54,184 $2.84 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $20.9 Million - $25.9 Million	456,554 Added 1703.69%	483,352 $25 Million
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $8.35 Million - $12.4 Million	-202,036 Reduced 88.29%	26,798 $1.58 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $4.97 Million - $6.39 Million	126,717 Added 124.09%	228,834 $9.84 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $1.08 Million - $1.23 Million	-30,205 Reduced 22.83%	102,117 $4 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $2.39 Million - $3.04 Million	-71,357 Reduced 35.03%	132,322 $4.87 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $152,353 - $172,902	4,628 Added 2.33%	203,679 $7.98 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $2.21 Million - $2.87 Million	68,155 Added 52.07%	199,051 $7.15 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $1.59 Million - $1.78 Million	-42,868 Reduced 24.67%	130,896 $5.67 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $6.32 Million - $6.94 Million	168,449 Added 3169.31%	173,764 $7.38 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $1.28 Million - $1.55 Million	-37,077 Reduced 87.46%	5,315 $234,000
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $1.23 Million - $1.31 Million	37,176 Added 712.73%	42,392 $1.54 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $165,357 - $191,837	5,182 Added 15241.18%	5,216 $185,000
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $21,419 - $22,726	-644 Reduced 94.99%	34 $1,000
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $21,018 - $23,153	678	678 $24,000

Others Institutions Holding PFE

# of Institutions

3,296

Shares Held

3.66B

Call Options Held

96M

Put Options Held

121M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $139B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account

Capstone Investment Advisors, LLC Pfizer Inc Transaction History